ÜBER DIESE EPISODE

Englisch
Vereinigte Staaten

TRANSKRIPT 🔗

VERGANGENE FOLGEN SUCHEN

Vorhandene Folgen von Proactive - Interviews for investors durchsuchen.

WEITERE EPISODEN IN DIESEM PODCAST

Renforth Resources Inc (CSE:RFR, OTCQB:RFHRF) CEO Nicole Brewster spoke with Proactive's Stephen Gunnion about new gold intersections at its Parbec deposit in Quebec, the planned resource review and next steps towards assessing development options. Two drillholes beneath recent surface discoveries…
Immunic Inc (NASDAQ:IMUX, FRA:10VA) CEO Erik Lundgren joined Proactive's Stephen Gunnion to discuss four posters the company will present at MSToronto2026, the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto from October 21–23. The presentations explore the potential of vidofludimus calcium, Immunic…
Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) CEO Matt Wood and CFO Amit Gupta spoke with Proactive's Stephen Gunnion after the battery technology company delivered FY2026 results ahead of market expectations and advanced plans to commercialise its nano-encapsulated sulfur (NES) technology. Gupta repo…
Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF) President and Chief Technology Officer Nicolas Loebel spoke with Proactive's Stephen Gunnion about the company’s £10 million fundraising, positive top-line Phase 3 results and plans to bring its nasal photodisinfection technology to the US market. Loebel …
Recce Pharmaceuticals Ltd chief executive James Graham talked with Proactive about the company’s Phase 3 trial of RECCE® 327 Gel, or R327G, for the treatment of diabetic foot infections in Indonesia and the upcoming review of trial data by an independent Data Monitoring Committee. Graham said the …
Rechtliche Hinweise: Der auf dieser Seite eingebettete Podcast und das Bildmaterial stammen von Proactive, das Eigentum seines Eigentümers ist und nicht mit Listen Notes, Inc. verbunden ist oder von diesen unterstützt wird.